Loading…
BioFDNC signed a three-party investment agreement on September 30, 2026, with the Gwangju-Jeonnam Special City and Hwasun County to build a third plant on a 12,240.1 m² site in Hwasun Bio-Pharmaceutical Industrial Complex. The plant will produce medical devices and biological products.
“이번 투자는 의료기기 사업을 회사의 새로운 성장동력으로 육성하기 위한 중요한 기반이 될 것”biofdnc-global.com
Summarized from public sources; check the original articles before acting on it.